Design Therapeutics, Inc.
DSGN · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $192 | $219 | $350 |
| - Cash | $15 | $20 | $14 | $23 |
| + Debt | $1 | $1 | $2 | $2 |
| Enterprise Value | – | $173 | $208 | $329 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$15 | -$0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$17 | -$19 | -$20 | -$17 |
| % Margin | – | – | – | – |
| Net Income | -$17 | -$19 | -$18 | -$14 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.3 | -0.34 | -0.31 | -0.24 |
| % Growth | 11.8% | -9.7% | -29.2% | – |
| Operating Cash Flow | -$11 | -$14 | -$17 | -$10 |
| Capital Expenditures | $0 | -$0 | -$0 | $0 |
| Free Cash Flow | -$11 | -$15 | -$17 | -$10 |